Novastage Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $15.8M

  • Investors
  • 1

Novastage General Information

Description

Developer of formulation technology in the transdermal patch and oral film. The company is developing transdermal patch and oral film drug products with lower toxicity, higher efficacy, and better patient compliance over other dosage forms, enabling clients to get better treatment.

Contact Information

Website
www.novastagepharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 17 Langshan Road
  • Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • No. 17 Langshan Road
  • Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novastage Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 18-Mar-2022 $15.8M Completed Pre-Clinical Trials
2. Secondary Transaction - Private 10-Jan-2022 Completed Pre-Clinical Trials
1. Corporate 13-Jul-2020 $2.83M $2.83M Completed Pre-Clinical Trials
To view Novastage’s complete valuation and funding history, request access »

Novastage Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Novastage Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025528758-A Risperidone transdermal delivery system and its manufacturing method and use Pending 04-Jan-2023
US-20260345514-A1 Stable rotigotine transdermal administration kit, and preparation method therefor and use thereof Pending 04-Jan-2023
WO-2024145845-A1 Stable rotigotine transdermal administration kit, and preparation method therefor and use thereof Inactive 04-Jan-2023
US-20260345513-A1 Stable transdermal drug delivery kit, preparation method therefor, and use thereof Pending 04-Jan-2023
WO-2024145846-A1 Stable transdermal drug delivery kit, preparation method therefor, and use thereof Inactive 04-Jan-2023
To view Novastage’s complete patent history, request access »

Novastage Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fuho Capital Venture Capital Minority
To view Novastage’s complete investors history, request access »

Ready to get started?

Request a free trial

Novastage FAQs

  • When was Novastage founded?

    Novastage was founded in 2019.

  • Where is Novastage headquartered?

    Novastage is headquartered in Shenzhen, China.

  • What industry is Novastage in?

    Novastage’s primary industry is Drug Discovery.

  • Is Novastage a private or public company?

    Novastage is a Private company.

  • What is Novastage’s current revenue?

    The current revenue for Novastage is .

  • How much funding has Novastage raised over time?

    Novastage has raised $18.6M.

  • Who are Novastage’s investors?

    Fuho Capital has invested in Novastage.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process